Alzheimer Disease
Company files new drug application for compound to treat Alzheimer disease
Published in Medical Letter on the CDC and FDA, July 10th, 2005
GX267 is a selective cholinergic muscarinic receptor agonist (M1 subtype) with properties suggesting the potential for both symptomatic and disease modification therapy in Alzheimer disease.
The M1 receptor plays an important role in memory and cognitive processing. Its activation has also been linked to decreases in 2 biochemical processes, AB production and tau protein phosphorylation, both of which are involved in the creation of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Sexual Abuse
Method to discriminate abusive from nonabusive situations reported - Vaccine Development
Statistical approaches to vaccine evaluation reviewed - Vaccine Efficacy
Racial and ethnic disparities exist in immunization coverage - Vaccine Efficacy
Statistical considerations for vaccine immunogenicity trials presented - Acinetobacter Baumannii Outbreaks
3rd-gen. cephalosporin therapy risk for VEB-1 ESBL A. baumannii outbreak - Acne
Trial of medical device for pimples information reported - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
